Cargando…
Delayed Cutaneous Adverse Reaction of the AstraZeneca COVID-19 Vaccine in a Breastfed Female Infant: A Coincidence or a Rare Effect?
The ChAdOx1 nCoV-19 vector vaccine (Vaxzevria, AstraZeneca, Cambridge, UK) was developed at Oxford University and is considered safe for the administration in lactating mothers. Nevertheless, as a novel vaccine, there are gaps in the knowledge regarding possible adverse events in breastfeeding infan...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9031970/ https://www.ncbi.nlm.nih.gov/pubmed/35455352 http://dx.doi.org/10.3390/vaccines10040602 |
_version_ | 1784692524533678080 |
---|---|
author | Diogo, Patrícia Correia, Gil Martins, João B. Soares, Rui Palma, Paulo J. Santos, João Miguel Gonçalves, Teresa |
author_facet | Diogo, Patrícia Correia, Gil Martins, João B. Soares, Rui Palma, Paulo J. Santos, João Miguel Gonçalves, Teresa |
author_sort | Diogo, Patrícia |
collection | PubMed |
description | The ChAdOx1 nCoV-19 vector vaccine (Vaxzevria, AstraZeneca, Cambridge, UK) was developed at Oxford University and is considered safe for the administration in lactating mothers. Nevertheless, as a novel vaccine, there are gaps in the knowledge regarding possible adverse events in breastfeeding infants of vaccinated mothers. This case report provides first-time data on a possible delayed, cutaneous, adverse reaction in a breastfed, 16-month-old female infant after the first administration of the AstraZeneca vaccine to her 33-year-old mother. Even though, no clinical adverse effects were observed in the mother, her daughter had a 2-day rash in the lower extremities and face. The infant’s cutaneous rashes might be a coincidental event. However, all skin lesions were analogous to previous descriptions and photographs of dermatologic reactions, which resolved spontaneously with no medical intervention, in people who had been vaccinated with other COVID-19 vaccines. Our aim is that this short report contributes to the enhancement of parental awareness about the possibility of similar skin rashes in breastfed children when the mothers receive a vaccination and the importance of reporting those adverse reactions to the competent authorities. |
format | Online Article Text |
id | pubmed-9031970 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-90319702022-04-23 Delayed Cutaneous Adverse Reaction of the AstraZeneca COVID-19 Vaccine in a Breastfed Female Infant: A Coincidence or a Rare Effect? Diogo, Patrícia Correia, Gil Martins, João B. Soares, Rui Palma, Paulo J. Santos, João Miguel Gonçalves, Teresa Vaccines (Basel) Case Report The ChAdOx1 nCoV-19 vector vaccine (Vaxzevria, AstraZeneca, Cambridge, UK) was developed at Oxford University and is considered safe for the administration in lactating mothers. Nevertheless, as a novel vaccine, there are gaps in the knowledge regarding possible adverse events in breastfeeding infants of vaccinated mothers. This case report provides first-time data on a possible delayed, cutaneous, adverse reaction in a breastfed, 16-month-old female infant after the first administration of the AstraZeneca vaccine to her 33-year-old mother. Even though, no clinical adverse effects were observed in the mother, her daughter had a 2-day rash in the lower extremities and face. The infant’s cutaneous rashes might be a coincidental event. However, all skin lesions were analogous to previous descriptions and photographs of dermatologic reactions, which resolved spontaneously with no medical intervention, in people who had been vaccinated with other COVID-19 vaccines. Our aim is that this short report contributes to the enhancement of parental awareness about the possibility of similar skin rashes in breastfed children when the mothers receive a vaccination and the importance of reporting those adverse reactions to the competent authorities. MDPI 2022-04-13 /pmc/articles/PMC9031970/ /pubmed/35455352 http://dx.doi.org/10.3390/vaccines10040602 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Case Report Diogo, Patrícia Correia, Gil Martins, João B. Soares, Rui Palma, Paulo J. Santos, João Miguel Gonçalves, Teresa Delayed Cutaneous Adverse Reaction of the AstraZeneca COVID-19 Vaccine in a Breastfed Female Infant: A Coincidence or a Rare Effect? |
title | Delayed Cutaneous Adverse Reaction of the AstraZeneca COVID-19 Vaccine in a Breastfed Female Infant: A Coincidence or a Rare Effect? |
title_full | Delayed Cutaneous Adverse Reaction of the AstraZeneca COVID-19 Vaccine in a Breastfed Female Infant: A Coincidence or a Rare Effect? |
title_fullStr | Delayed Cutaneous Adverse Reaction of the AstraZeneca COVID-19 Vaccine in a Breastfed Female Infant: A Coincidence or a Rare Effect? |
title_full_unstemmed | Delayed Cutaneous Adverse Reaction of the AstraZeneca COVID-19 Vaccine in a Breastfed Female Infant: A Coincidence or a Rare Effect? |
title_short | Delayed Cutaneous Adverse Reaction of the AstraZeneca COVID-19 Vaccine in a Breastfed Female Infant: A Coincidence or a Rare Effect? |
title_sort | delayed cutaneous adverse reaction of the astrazeneca covid-19 vaccine in a breastfed female infant: a coincidence or a rare effect? |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9031970/ https://www.ncbi.nlm.nih.gov/pubmed/35455352 http://dx.doi.org/10.3390/vaccines10040602 |
work_keys_str_mv | AT diogopatricia delayedcutaneousadversereactionoftheastrazenecacovid19vaccineinabreastfedfemaleinfantacoincidenceorarareeffect AT correiagil delayedcutaneousadversereactionoftheastrazenecacovid19vaccineinabreastfedfemaleinfantacoincidenceorarareeffect AT martinsjoaob delayedcutaneousadversereactionoftheastrazenecacovid19vaccineinabreastfedfemaleinfantacoincidenceorarareeffect AT soaresrui delayedcutaneousadversereactionoftheastrazenecacovid19vaccineinabreastfedfemaleinfantacoincidenceorarareeffect AT palmapauloj delayedcutaneousadversereactionoftheastrazenecacovid19vaccineinabreastfedfemaleinfantacoincidenceorarareeffect AT santosjoaomiguel delayedcutaneousadversereactionoftheastrazenecacovid19vaccineinabreastfedfemaleinfantacoincidenceorarareeffect AT goncalvesteresa delayedcutaneousadversereactionoftheastrazenecacovid19vaccineinabreastfedfemaleinfantacoincidenceorarareeffect |